Lexicon Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes.

CEO

Lonnel Coats

CEOLonnel Coats

Employees

285

Employees285

Headquarters

The Woodlands, Texas

HeadquartersThe Woodlands, Texas

Founded

1995

Founded1995

Employees

285

Employees285

LXRX Key Statistics

Market cap

405.06M

Market cap405.06M

Price-Earnings ratio

-2.08

Price-Earnings ratio-2.08

Dividend yield

—

Dividend yield—

Average volume

3.20M

Average volume3.20M

High today

$1.77

High today$1.77

Low today

$1.51

Low today$1.51

Open price

$1.58

Open price$1.58

Volume

7.09M

Volume7.09M

52 Week high

$3.79

52 Week high$3.79

52 Week low

$0.92

52 Week low$0.92

LXRX News

TipRanks 3d

Lexicon Pharmaceuticals CEO Lonnel Coats Announces Retirement - TipRanks.com - TipRanks

An announcement from Lexicon Pharmaceuticals (LXRX) is now available. Lonnel Coats has announced his retirement as the CEO and board member of Lexicon Pharmace...

TipRanks 3d

Lexicon announces CEO Lonnel Coats will retire July 7

Lexicon Pharmaceuticals announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of its board of directors,...

Seeking Alpha 3d

Lexicon Pharmaceuticals announces retirement of CEO Lonnel Coats

Entering text into the input field will update the search result below...